Lung Cancers Completed Phase 1 Trials for Vandetanib (DB05294)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00734890Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or LymphomaTreatment
NCT00506051ZD6474(Vandetanib) + Alimta Combo StudyTreatment